Corrado Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-50,100
| Closed | -$120K | – | 109 |
|
|
2018
Q1 | $120K | Sell |
50,100
-11,500
| -19% | -$27.5K | 0.07% | 112 |
|
|
2017
Q4 | $241K | Sell |
61,600
-33,500
| -35% | -$131K | 0.14% | 93 |
|
|
2017
Q3 | $240K | Sell |
95,100
-41,450
| -30% | -$105K | 0.14% | 95 |
|
|
2017
Q2 | $377K | Sell |
136,550
-114,475
| -46% | -$316K | 0.21% | 76 |
|
|
2017
Q1 | $489K | Buy |
251,025
+60,425
| +32% | +$118K | 0.28% | 67 |
|
|
2016
Q4 | $200K | Buy |
190,600
+8,700
| +5% | +$9.13K | 0.12% | 99 |
|
|
2016
Q3 | $198K | Buy |
181,900
+78,600
| +76% | +$85.6K | 0.13% | 93 |
|
|
2016
Q2 | $73K | Buy |
103,300
+76,200
| +281% | +$53.8K | 0.05% | 99 |
|
|
2016
Q1 | $32K | Buy |
+27,100
| New | +$32K | 0.02% | 90 |
|
|
2015
Q3 | – | Sell |
-79,450
| Closed | -$328K | – | 67 |
|
|
2015
Q2 | $328K | Sell |
79,450
-26,250
| -25% | -$108K | 0.15% | 72 |
|
|
2015
Q1 | $458K | Buy |
+105,700
| New | +$458K | 0.2% | 57 |
|